Second Sight Medical (EYES) Reports Q1 Loss of $0.14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EYES Hot Sheet
Join SI Premium – FREE
Second Sight Medical (NASDAQ: EYES) reported Q1 EPS of ($0.14), versus ($0.16) reported last year. Revenue for the quarter came in at $1 million, versus $1 million reported last year.
For earnings history and earnings-related data on Second Sight Medical (EYES) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corpay, Inc. (CPAY) Tops Q3 EPS by 35c; offers guidance
- Amplitude, Inc. (AMPL) Tops Q3 EPS by 1c ; Offers Guidance
- e.l.f. Beauty, Inc. (ELF) Tops Q2 EPS by 64c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
